Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement 
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
ATLANTA, Oct. 23, 2017 -- Crawford & Company® (www.crawfordandcompany.com) (NYSE:CRD-A) (NYSE:CRD-B), the world's largest publicly listed independent provider of claims management solutions to insurance companies and self-insured entities, will issue its earnings release for its third quarter ended September 30, 2017, on Monday, Nov. 6, 2017, at 6:45 a.m. Eastern time.
The quarterly conference call, to discuss Crawford®’s quarterly earnings and other developments, will be held on Monday, Nov. 6, 2017, at 4:30 p.m. Eastern time. The call can be accessed by dialing 1-800-374-2518, Conference ID: 6374542.
The financial and statistical information for the earnings call will be placed on Crawford & Company's website at www.crawfordandcompany.com/quarterlyreleases.
This call is being webcast by Nasdaq and can be accessed on the Crawford & Company website at http://www.crawfordandcompany.com/about-us/investor-relations/quarterly-earnings.
The webcast is also being distributed through the Thomson StreetEvents Network. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event management site.
An attachment accompanying this release is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a5b9ab25-bd60-4184-9778-5429c647437d
About Crawford®
Based in Atlanta, Crawford & Company (NYSE:CRD‐A) (NYSE:CRD‐B) is the world’s largest publicly listed independent provider of claims management solutions to insurance companies and self‐insured entities with an expansive global network serving clients in more than 70 countries. The Company’s two classes of stock are substantially identical, except with respect to voting rights and the Company’s ability to pay greater cash dividends on the non-voting Class A Common Stock (CRD-A) than on the voting Class B Common Stock (CRD-B), subject to certain limitations. In addition, with respect to mergers or similar transactions, holders of CRD-A must receive the same type and amount of consideration as holders of CRD-B, unless different consideration is approved by the holders of 75% of CRD-A, voting as a class. More information is available at www.crawfordandcompany.com.
Bruce Swain
Chief Financial Officer
404-300-1051
[email protected]
